We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Specialized Stain Enables Exceptional Bone Marrow Diagnostic Pathology

By LabMedica International staff writers
Posted on 13 Mar 2014
A new tissue stain has been specially developed to provide superior clarity of differentiation and detail in bone marrow tissue samples for disease diagnosis. More...


Dako (Glostrup, Denmark), an Agilent Technologies (Santa Clara, CA, USA) company, has now added its new Jenner-Wright Giemsa stain to Dako's broad palette of automated stains – its Artisan Link portfolio. Dako is releasing the stain in its continuing mission to provide pathology labs with the most advanced special stain solutions and the broadest portfolio.

The Jenner-Wright Giemsa stain is designed to give pathologists an added dimension to the visualization of the cell morphology by providing clear differentiation and detail of hematopoietic cells in bone marrow samples for the diagnosis of diseases, such as cancer, aplastic anemia, and myelofibrosis.

The Artisan portfolio provides the broadest range of automated special stains available—currently consisting of 31 high-quality stains, covering most of a typical laboratory’s special stain needs. Dako also plans to add more stains to the portfolio.

The portfolio also enables labs to take advantage of the productivity benefits possible through automation with the Artisan Link Pro instrument. Laboratories that routinely do special stains will benefit from a 64% reduction in hands-on time with Artisan Link Pro, compared with the same protocols performed manually. Significant gains in lab safety can be realized because the Artisan Link Pro and its ready-to-use reagents are closed, minimizing exposure to hazardous chemicals, and can be connected to ventilation systems. The instrument also features a unique waste separation system that reduces hazardous waste generation, helping labs minimize disposal and associated costs.

"Dako’s Jenner-Wright Giemsa special stain for bone marrow is excellent, and allows us, for the first time, to automate the diagnosis of various diseases using bone marrow tissue," said Prof. Hermann Herbst, director of the Vivantes Pathology Department in Berlin. "Artisan Link Pro stains are fabulous to look at. This stain in particular offers an unprecedented ability to use bone marrow and provides exceptionally clear differentiation and detail."

Related Links:

Dako
Dako's Jenner-Wright Giemsa kit
Agilent Technologies 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.